• Mon news: Novartis in $745M radiopharma pact. Novo launches Wegovy in China. COVID-era telehealth prescribing extended. Hims & Hers GLP-1 tracker. Promising Gilead liver disease trial. See more on our front page

Has Diversity Ever Really Been A Strength?





We can benefit from diversity of options, experience, backgrounds, etc., but should choose the best people to hire and promote abs we are not doing that so as to ensure Diversity. It isn’t working